Being obese can make you more likely to be unemployed
The effect of obesity on unemployment is more than twice as large as previously thought, finds a UK Biobank study of genetic evidence.
3 hours ago
0
0
Endocrinology news
Semaglutide and other GLP-1 drugs not linked to risk of degenerative eye disease in adults with type 2 diabetes
An estimated 27% of U.S. adults with diabetes are using glucagon-like peptide-1 receptor agonists (GLP-1 RAs)—a type of medication that mimics the GLP-1 hormone—to lower blood sugar and support weight loss. Some research ...
4 hours ago
0
0
GLP-1 receptor agonist use does not increase insulin discontinuation with type 2 diabetes
For veterans with type 2 diabetes (T2D) receiving basal insulin therapy, the addition of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) does not increase the rate of insulin discontinuation compared with other glucose-lowering ...
19 hours ago
0
3
Study identifies patients with obesity most likely to benefit from GLP-1-based treatment
Why do some people lose substantial weight with GLP-1-based medications while others see more modest results? A Mayo Clinic study offers a potential answer by identifying a distinct biological subtype of obesity that responds ...
Jul 16, 2026
0
3
Ozempic-like drugs have more benefits to the body than just losing weight, meta-analysis shows
A meta-analysis of 10 randomized controlled trials involving more than 23,000 participants, presented at the International Congress on Obesity (ICO 2026), hosted by the World Obesity Federation (WOF) in Mexico City, Mexico ...
Jul 16, 2026
0
3
What's driving the obesity pandemic?
New research presented at the International Congress on Obesity (ICO2026), hosted by the World Obesity Federation (WOF) in Mexico City, Mexico, (15–17 July) asks what is driving the obesity pandemic.
Jul 16, 2026
0
5
Changing behavior to aid weight loss may be linked to reduced risks of obesity related cancers
A new systematic review and meta-analysis presented at the International Congress on Obesity (ICO2026), hosted by the World Obesity Federation (WOF) in Mexico City, Mexico, July 15–17, is the first study to show that behavioral ...
Jul 15, 2026
0
3
Internet searches on weight-loss medications have increased 25-fold since the launch of GLP-1 drugs
Public interest in obesity medication has risen 25-fold since the launch of GLP-1 receptor agonist drugs, new research presented at the International Congress on Obesity (ICO2026) in Mexico City, Mexico, hosted by the World ...
Jul 15, 2026
0
19
Review calls for Mexico to add liver health to chronic disease programs
Liver disease may affect close to half of adults in Mexico, yet the country tracks it far less closely than the diabetes and obesity to which it is linked, according to a new paper by Jeffrey Lazarus, professor at the CUNY ...
Jul 15, 2026
0
3
Primary care initiation of continuous glucose monitoring is effective
Among adults with insulin-treated diabetes, initiation of continuous glucose monitoring (CGM) by primary care clinicians is associated with clinically meaningful improvements in hemoglobin A1c (HbA1c) and significant reductions ...
Jul 14, 2026
0
3
